14401-60-6 Usage
Description
2-BROMO-5-METHYL-4-NITROPHENOL, with the molecular formula C7H6BrNO3, is a yellow crystalline solid that serves as a versatile chemical intermediate. It is known for its anti-bacterial and anti-fungal properties, making it a valuable component in the production of fungicides and pharmaceuticals. Additionally, it is utilized as a reagent in organic synthesis and as a dye intermediate.
Uses
Used in Pharmaceutical Industry:
2-BROMO-5-METHYL-4-NITROPHENOL is used as an intermediate in the synthesis of various pharmaceuticals for its anti-bacterial and anti-fungal properties, contributing to the development of effective treatments against infections.
Used in Agrochemical Industry:
In the agrochemical industry, 2-BROMO-5-METHYL-4-NITROPHENOL is used as a key component in the production of fungicides, helping to protect crops from fungal infections and ensuring a stable food supply.
Used in Organic Synthesis:
2-BROMO-5-METHYL-4-NITROPHENOL is used as a reagent in organic synthesis, enabling the creation of a wide range of organic compounds for various applications, including the development of new materials and pharmaceuticals.
Used in Dye Industry:
As a dye intermediate, 2-BROMO-5-METHYL-4-NITROPHENOL is utilized in the production of dyes, contributing to the vibrant colors and hues found in textiles, plastics, and other materials.
It is crucial to handle 2-BROMO-5-METHYL-4-NITROPHENOL with care due to its toxic and harmful properties, ensuring the safety of both individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 14401-60-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,4,0 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 14401-60:
(7*1)+(6*4)+(5*4)+(4*0)+(3*1)+(2*6)+(1*0)=66
66 % 10 = 6
So 14401-60-6 is a valid CAS Registry Number.
14401-60-6Relevant articles and documents
QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS
-
Page/Page column 151-153, (2020/04/25)
The present application relates to novel quinazoline compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.
Glucokinase Activators
-
Page/Page column 109-110, (2009/12/05)
Compounds are provided for use with glucokinase that comprise the formula: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
INDOLES AS 5-HT6 MODULATORS
-
Page/Page column 119, (2008/06/13)
The present invention relates to novel compounds of formula (I) wherein m, n, R0, R1, R2, R3 and R4 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for t
